Rubana N. Kalyani

ART (Protein Product of Agouti-Related Transcript) as an Antagonist of MC-3 and MC-4 Receptors

Tung M. Fong, Cheri Mao, Tanya MacNeil et al. · Biochemical and Biophysical Research Communications · 1997 · 219 citations

Medicine, Molecular Biology, Pharmacology +12

Design and Pharmacology of <i>N</i>-[(3<i>R</i>)-1,2,3,4-Tetrahydroisoquinolinium- 3-ylcarbonyl]-(1<i>R</i>)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1<i>H</i>-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (<b>1</b>), a Potent, Selective, Melanocortin Subtype-4 Receptor Agonist

Iyassu K. Sebhat, William J. Martin, Zhixiong Ye et al. · Journal of Medicinal Chemistry · 2002 · 193 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal‐salt diet

Jules I. Schwartz, K. Vandormael, Marie-Pierre Malice et al. · Clinical Pharmacology & Therapeutics · 2002 · 158 citations

Pharmacy, Geriatric Medicine, Pharmacotherapy +11

Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials

Edward M Vital, Joan T. Merrill, Eric F. Morand et al. · Annals of the Rheumatic Diseases · 2022 · 142 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Selective, High Affinity Peptide Antagonists of α-Melanotropin Action at Human Melanocortin Receptor 4:  Their Synthesis and Biological Evaluation in Vitro

Maria A. Bednarek, Tanya MacNeil, Rubana N. Kalyani et al. · Journal of Medicinal Chemistry · 2001 · 97 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14